Clean Yield Group’s Cocrystal Pharma COCP Stock Holding History

Clean Yield Group’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$422	Hold	418	–	–	﹤0.01%	377
2025 Q4	$409	Hold	418	–	–	﹤0.01%	398
2025 Q3	$523	Hold	418	–	–	﹤0.01%	403
2025 Q2	$623	Hold	418	–	–	﹤0.01%	386
2025 Q1	$594	Hold	418	–	–	﹤0.01%	425
2024 Q4	$844	Hold	418	–	–	﹤0.01%	439
2024 Q3	$736	Buy	+418	New	+$814	﹤0.01%	454
2023 Q3	–	Sell	-418	Closed	-$999	–	387
2023 Q2	$999	Hold	418	–	–	﹤0.01%	384
2023 Q1	$832	Hold	418	–	–	﹤0.01%	404
2022 Q4	$815	Buy	418 +1	+0.2%	+$3	﹤0.01%	432
2022 Q3	$1K	Hold	417	–	–	﹤0.01%	429
2022 Q2	$2K	Hold	417	–	–	﹤0.01%	401
2022 Q1	$3K	Hold	417	–	–	﹤0.01%	422
2021 Q4	$3K	Hold	417	–	–	﹤0.01%	424
2021 Q3	$5K	Hold	417	–	–	﹤0.01%	421
2021 Q2	$6K	Buy	+417	New	+$6.34K	﹤0.01%	404
2021 Q1	–	Sell	-417	Closed	-$7K	–	198
2020 Q4	$7K	Buy	+417	New	+$5.79K	﹤0.01%	370

Other funds holding COCP

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T3 Companies New York $76.8M AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Clean Yield Group's COCP Position: Q1 2026 in Review

Clean Yield Group held its Cocrystal Pharma (COCP) position steady in Q1 2026 at 418 shares worth $422. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Clean Yield Group first reported a position in COCP in Q4 2020 and has held it in 17 quarters since. The position peaked at $7K in Q4 2020. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

Clean Yield Group held 418 shares of Cocrystal Pharma worth $422 as of Q1 2026.
Clean Yield Group left its Cocrystal Pharma share count unchanged in Q1 2026.
Cocrystal Pharma made up ﹤0.01% of Clean Yield Group's portfolio in Q1 2026, its #377 holding.
Clean Yield Group first reported a position in Cocrystal Pharma in Q4 2020 and has held it in 17 quarters since.
Clean Yield Group's Cocrystal Pharma position peaked at $7K in Q4 2020.
26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.